Novadoz Pharmaceuticals, is the Marketing Partner for MSN Lab’s portfolio of finished dosage forms. Novadoz Pharma’s core focus is to be a reliable supplier of affordable generics to key regulatory markets like USA and Canada while emerging as an industry leader by introducing new products consistently.
MSN produces high quality generics with a concentrated focus on maintaining the highest cGMP standards. This has yielded a stellar track record in the U.S with the FDA, as well as in other regulated markets.
Our strong and skilled process for developing and submitting API and finished dose generic applications for FDA approval has awarded us with a deep and extensive product pipeline. Our robust pipeline constantly grows as we continuously submit both API and finished dose products for future approvals.
Backed by MSN Group’s backward integration capabilities, Novadoz is able to offer trusted quality throughout the product value chain. The company’s expertise in developing products right from KSMs (key starting materials), and product intermediates to APIs and finished dosages reinforces the products’ integrity and affordability.
A global leader in the development & manufacturing of APIs (active pharmaceutical ingredients), MSN is also the world’s leading active DMFs (Drug Master Files) catering to the API needs of a majority of U.S based generic pharma companies.
Novadoz is currently marketing oral solids (tablets, capsules) as well as injectables, including oncology and specialty products.
Mission:
Novadoz Pharmaceuticals is committed to being a reliable and consistent supplier of safe, effective, and affordable generic pharmaceuticals. Our unwavering focus on quality, ensures that patients who take our medications will have a reliable and trusted manufacturing source. The foundation of our organization is built on principles of integrity, and the strength of the relationships we maintain with our employees and customers.
Go To MSN Labs